The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
39 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $44,585,698 in first-year total cost, median $747,189.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-E (55)]31
- Special Emphasis Panel[ZRG1 ETTN-N (55)]2
- Special Emphasis Panel[ZRG1-ETTN-E(55)R]2
- Special Emphasis Panel[ZRG1-ETTN-N(55)R]2
- Biostatistical Methods and Research Design Study Section[BMRD]1
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL3
- UNIVERSITY OF CALIFORNIA, SAN DIEGO3
- WASHINGTON UNIVERSITY3
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE2
- UNIVERSITY OF NORTH TEXAS HLTH SCI CTR2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Establishing MicroRNA Biomarkers for Diagnosing Alzheimer's Disease & Predicting Progression1RF1AG059392-01A1 | SAUGSTAD, JULIE ANNE | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $3,429,850 | ZRG1 |
| 2019 | Network Modelling of Multimodal Dynamics in Alzheimer’s Disease and Dementia1RF1AG062196-01 | NAGARAJAN, SRIKANTAN S.RAJ, ASHISH | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $2,955,738 | ZRG1 |
| 2019 | Comprehensive diagnosis of Alzheimer's disease by detection of misfolded oligomers in biological fluids1RF1AG055053-01A1 | SOTO, CLAUDIO | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $2,897,592 | ZRG1 |
| 2019 | Building blood based DNA methylation signatures for AD that are reflective of CNS changes1RF1AG061127-01 | WANG, LILY | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $1,918,750 | ZRG1 |
| 2019 | Blood Biomarker for Alzheimer's Disease: Phospholipids1RF1AG059288-01A1 | GERMAN, DWIGHT C.MCDONALD, JEFF G | UT SOUTHWESTERN MEDICAL CENTER, TX | $1,215,000 | ZRG1 |
| 2019 | Imaging Advancements in Small Vessel and CSF Flow Pathophysiology of Pre-clinical Alzheimer's Disease1R01AG063525-01 | AIZENSTEIN, HOWARD JCOHEN, ANN D.IBRAHIM, TAMER S | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $763,247 | ZRG1 |
| 2019 | Iron as an Imaging Biomarker for Inflammation in AD1R01AG061120-01 | ZEINEH, MICHAEL M | STANFORD UNIVERSITY, CA | $714,464 | ZRG1 |
| 2019 | Statistical methods to improve reproducibility and reduce technical variability in heterogeneous multimodal neuroimaging studies of Alzheimer’s Disease1R01AG063752-01 | TUDORASCU, DANA L | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $619,772 | BMRD |
| 2019 | Fluorescence ocular imaging for preliminarily screening of Alzheimer's1R56AG059814-01A1 | RAN, CHONGZHAO | MASSACHUSETTS GENERAL HOSPITAL, MA | $571,820 | ZRG1 |
| 2019 | Cognitive challenge to reveal presymptomatic Alzheimer's disease1R56AG063857-01 | ARAKAKI, XIANGHONGHARRINGTON, MICHAEL GORDON | HUNTINGTON MEDICAL RESEARCH INSTITUTES, CA | $512,673 | ZRG1 |
| 2018 | Fractal motor activity regulation and the risk for Alzheimers disease in middle-to-old aged adults1RF1AG059867-01 | HU, KUN | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,722,811 | ZRG1 |
| 2018 | An Alzheimer's Blood Test for Primary Care1R01AG058537-01 | O'BRYANT, SID EYAFFE, KRISTINE | UNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX | $2,195,743 | ZRG1 |
| 2018 | Model-based cerebrovascular markers extracted from hemodynamic data for diagnosing MCI or AD and predicting disease progression.1R01AG058162-01A1 | BILLINGER, SANDRA ACHUI, HELENA CHANGMARMARELIS, VASILIS ZZHANG, RONG | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $2,144,503 | ZRG1 |
| 2018 | Multi-center development of a novel diagnostic test for Alzheimer's disease1R01AG059424-01 | FARLOW, MARTIN RHYSKOWALL, NEIL W.QIU, WEI QIAO WENDY | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $1,306,078 | ZRG1 |
| 2018 | CMP3: A CSF Multiple Pathophysiology Panel for Clinical Trials in Alzheimer's Disease1RF1AG059856-01 | ARNOLD, STEVEN E | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,256,900 | ZRG1 |
| 2018 | CSF Clearance in Sporadic Alzheimer's Disease1R01AG057848-01A1 | LI, YI | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $842,089 | ZRG1 |
| 2018 | Visceral fat, systemic inflammation and brain-tissue health: towards early detection and prevention of Alzheimer’s disease.1R01AG056726-01A1 | PAUSOVA, ZDENKA | HOSPITAL FOR SICK CHLDRN (TORONTO), ON | $530,608 | ZRG1 |
| 2018 | Sleep and Electroencephalography Biomarkers of Alzheimer's Disease1R01AG059507-01 | JU, YO-EL S | WASHINGTON UNIVERSITY, MO | $403,908 | ZRG1 |
| 2018 | Designing array-AFM to study cellular interactions mediating transmission and progression of AD pathophysiology in brain1R56AG058069-01A1 | LAL, RATNESHWAR | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $377,463 | ZRG1 |
| 2018 | CSF Clearance with 11C-Butanol PET Predicts Amyloid Deposition1R56AG058913-01 | DE LEON, MONY J.RUSINEK, HENRY | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $322,070 | ZRG1 |
| 2017 | Pupillary Responses as a Risk and Staging Biomarker of Preclinical Alzheimer's Disease1RF1AG054509-01 | BONDI, MARK WGRANHOLM, ERIC L | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $2,948,987 | ZRG1 |
| 2017 | Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG1R01AG054081-01A1 | DICKERSON, BRADFORD CPRERAU, MICHAEL JPURDON, PATRICK L. | MASSACHUSETTS GENERAL HOSPITAL, MA | $854,981 | ZRG1 |
| 2017 | Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)1R01AG057898-01 | DEVANAND, DAVANGERE PLUCHSINGER, JOSE ALEJANDRO | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $811,920 | ZRG1 |
| 2017 | Biomarkers of ABCA1 mediated functions in Alzheimers disease1R01AG055770-01 | YASSINE, HUSSEIN N | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $780,465 | ZRG1 |
| 2017 | Blood Base Bioenergetic Profiling: A Novel Approach for Identifying Alzheimer's Disease Risk and Pathology1R01AG054523-01A1 | MOLINA, ANTHONY J | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $766,314 | ZRG1 |
| 2017 | Quantification of Neuroinflammation inAlzheimer's Disease Using Diffusion BasisSpectrum Imaging1R01AG054567-01A1 | BENZINGER, TAMMIE LEE SMITHWANG, YONG | WASHINGTON UNIVERSITY, MO | $747,189 | ZRG1 |
| 2017 | New Quantitative Neuroimaging Metrics of Structural and Functional Connectivity of the Locus Coeruleus as a Novel Biomarker of Alzheimer's Disease Pathogenesis and Progression1R01AG054049-01A1 | BONDI, MARK WFRANK, LAWRENCE R | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $690,083 | ZRG1 |
| 2017 | Blood-based biomarkers for early detection of Alzheimer's disease1R01AG054053-01A1 | NAGELE, ROBERT G | ROWAN UNIVERSITY SCHOOL/OSTEOPATHIC MED, NJ | $688,674 | ZRG1 |
| 2017 | Novel Imaging Biomarker for Treating Spatial Memory Loss in Prodromal Alzheimer's Disease Models1R01AG058171-01 | BENNETT, BRIAN MBERKOWITZ, BRUCE A.MURPHY, GEOFFREY GTHIBAULT, OLIVIER | WAYNE STATE UNIVERSITY, MI | $599,186 | ZRG1 |
| 2017 | A Blood Test for Screening Into Alzheimer's Prevention Trials1R01AG058252-01 | O'BRYANT, SID ERISSMAN, ROBERT | UNIVERSITY OF NORTH TEXAS HLTH SCI CTR, TX | $578,888 | ZRG1 |
| 2017 | In vivo MRI Biomarkers of Microstructural Correlates of Brain Pathology in Preclinical and Early Alzheimer Disease1R01AG054513-01A1 | YABLONSKIY, DMITRIY A | WASHINGTON UNIVERSITY, MO | $509,695 | ZRG1 |
| 2017 | Retinal Imaging of Alzheimer's Disease Pathology1R01AG056478-01 | KORONYO-HAMAOUI, MAYA | CEDARS-SINAI MEDICAL CENTER, CA | $437,500 | ZRG1 |
| 2017 | Novel Blood Biomarker of Alzheimer's disease Using Oral Glucose Tolerance1R01AG057725-01 | OH, ESTHER SEUNGHEE | JOHNS HOPKINS UNIVERSITY, MD | $410,240 | ZRG1 |
| 2017 | Advanced machine learning algorithms that integrate genomewide, longitudinal MRI and demographic data to predict future cognitive decline toward dementia1R01AG053949-01A1 | SABUNCU, MERT RORY | CORNELL UNIVERSITY, NY | $407,500 | ZRG1 |
| 2016 | A sleep electroencephalography biomarker predicting Alzheimer's disease pathology1RF1AG054019-01 | WALKER, MATTHEW P | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $4,122,300 | ZRG1 |
| 2016 | CSF, MRI, and PET biomarkers of neuroinflammation in Alzheimer's disease1R01AG054046-01 | HU, WILLIAM TZU-LUNG | EMORY UNIVERSITY, GA | $770,283 | ZRG1 |
| 2016 | Protein variants as blood based biomarkers for diagnosing and staging AD1R01AG054048-01 | SIERKS, MICHAEL R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $363,437 | ZRG1 |
| 2016 | Modeling Axonal Density and Inflammation-Associated Cellularity in Alzheimer’s Disease Using Hybrid Diffusion Imaging1R01AG053993-01 | WU, YU-CHIEN | INDIANA UNIVERSITY INDIANAPOLIS, IN | $319,565 | ZRG1 |
| 2016 | Characterizing the glymphatic peri-vascular connectome and its disruption in AD1RF1AG053991-01 | BENVENISTE, HELENE DNEDERGAARD, MAIKENTANNENBAUM, ALLEN R.VAN NOSTRAND, WILLIAM E. | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $77,412 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.